{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:28:12Z","timestamp":1759332492759},"reference-count":40,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.3892\/ijo.2014.2716","type":"journal-article","created":{"date-parts":[[2014,10,21]],"date-time":"2014-10-21T07:22:42Z","timestamp":1413876162000},"page":"113-122","source":"Crossref","is-referenced-by-count":11,"title":["Downregulation of thymidylate synthase and E2F1 by arsenic trioxide in mesothelioma"],"prefix":"10.3892","volume":"46","author":[{"given":"SZE-KWAN","family":"LAM","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUAN-YUAN","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHUN-YAN","family":"ZHENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JAMES CHUNG-MAN","family":"HO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,10,21]]},"reference":[{"key":"key20180107184206_b1-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejcts.2007.09.044","article-title":"Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients","volume":"33","author":"Borasio","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"key20180107184206_b2-ijo-46-01-0113","first-page":"19","article-title":"Effects of treatment regimens on survival in patients with malignant pleural mesothelioma","volume":"17","author":"Abakay","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key20180107184206_b3-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1535-6108(04)00080-7","article-title":"Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme","volume":"5","author":"Rahman","year":"2004","journal-title":"Cancer Cell"},{"key":"key20180107184206_b4-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/sonc.2002.34268","article-title":"Incorporation of pemetrexed (Alimta) into the treatment of non-small cell lung cancer (thoracic tumors)","volume":"29","author":"Bunn","year":"2002","journal-title":"Semin Oncol"},{"key":"key20180107184206_b5-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0006-2952(03)00287-9","article-title":"Induction of resistance to the multitargeted antifolate Pemetrexed (ALIMTA) in WiDr human colon cancer cells is associated with thymidylate synthase overexpression","volume":"66","author":"Sigmond","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"key20180107184206_b6-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/JTO.0b013e318283da3e","article-title":"Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma","volume":"8","author":"Lustgarten","year":"2013","journal-title":"J Thorac Oncol"},{"key":"key20180107184206_b7-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/JTO.0b013e318287c224","article-title":"Reduced folate carrier and folylpolyglutamate synthetase, but not thymidylate synthase predict survival in pemetrexed-treated patients suffering from malignant pleural mesothelioma","volume":"8","author":"Mairinger","year":"2013","journal-title":"J Thorac Oncol"},{"key":"key20180107184206_b8-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1470-2045(04)01492-5","article-title":"Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development","volume":"5","author":"Fennell","year":"2004","journal-title":"Lancet Oncol"},{"key":"key20180107184206_b9-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00228-002-0514-x","article-title":"Systemic availability of arsenic from oral arsenic-trioxide used to treat patients with hematological malignancies","volume":"58","author":"Kumana","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"key20180107184206_b10-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.3892\/ijo.2014.2364","article-title":"Downregulation of thymidylate synthase with arsenic trioxide in lung adenocarcinoma","volume":"44","author":"Lam","year":"2014","journal-title":"Int J Oncol"},{"key":"key20180107184206_b11-ijo-46-01-0113","first-page":"1157","article-title":"Arsenic trioxide suppresses thymidylate synthase in 5-FU-resistant colorectal cancer cell line HT29 in vitro re-sensitizing cells to 5-FU","volume":"30","author":"Subbarayan","year":"2010","journal-title":"Anticancer Res"},{"key":"key20180107184206_b12-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/jcp.22397","article-title":"Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells","volume":"226","author":"Eguchi","year":"2011","journal-title":"J Cell Physiol"},{"key":"key20180107184206_b13-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jtcvs.2013.08.035","article-title":"Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro","volume":"147","author":"You","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key20180107184206_b14-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1038\/srep03105","article-title":"Requirement for phosphorylation of P53 at Ser312 in suppression of chemical carcinogenesis","volume":"3","author":"Slee","year":"2013","journal-title":"Sci Rep"},{"key":"key20180107184206_b15-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.lungcan.2013.05.012","article-title":"Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer","volume":"81","author":"Li","year":"2013","journal-title":"Lung Cancer"},{"key":"key20180107184206_b16-ijo-46-01-0113","first-page":"1505","article-title":"Effects of thymidylate synthase inhibition on thymidine kinase activity and nucleoside transporter expression","volume":"55","author":"Pressacco","year":"1995","journal-title":"Cancer Res"},{"key":"key20180107184206_b17-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/1471-2407-12-338","article-title":"Generation of a selectively cytotoxic fusion protein against p53 mutated cancers","volume":"12","author":"Kousparou","year":"2012","journal-title":"BMC Cancer"},{"key":"key20180107184206_b18-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1182\/blood.V89.9.3354","article-title":"Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients","volume":"89","author":"Shen","year":"1997","journal-title":"Blood"},{"key":"key20180107184206_b19-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/09603123.2011.628792","article-title":"Cancer incidence and pattern of arsenic concentration in drinking water wells in Cordoba, Argentina","volume":"22","author":"Aballay","year":"2012","journal-title":"Int J Environ Health Res"},{"key":"key20180107184206_b20-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1289\/ehp.1205875","article-title":"The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem","volume":"121","author":"Naujokas","year":"2013","journal-title":"Environ Health Perspect"},{"key":"key20180107184206_b21-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1083\/jcb.201112044","article-title":"The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies","volume":"198","author":"de The","year":"2012","journal-title":"J Cell Biol"},{"key":"key20180107184206_b22-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/sj.leu.2401650","article-title":"Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia","volume":"14","author":"Cai","year":"2000","journal-title":"Leukemia"},{"key":"key20180107184206_b23-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1182\/blood.V94.6.2102","article-title":"Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway","volume":"94","author":"Jing","year":"1999","journal-title":"Blood"},{"key":"key20180107184206_b24-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1182\/blood.V98.13.3762","article-title":"Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage","volume":"98","author":"Mahieux","year":"2001","journal-title":"Blood"},{"key":"key20180107184206_b25-ijo-46-01-0113","first-page":"3065","article-title":"Arsenic trioxide-mediated growth inhibition in MC\/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis","volume":"60","author":"Park","year":"2000","journal-title":"Cancer Res"},{"key":"key20180107184206_b26-ijo-46-01-0113","first-page":"377","article-title":"Arsenic trioxide induces apoptosis in chronic myelogenous leukemia K562 cells: possible involvement of p38 MAP kinase","volume":"35","author":"Shim","year":"2002","journal-title":"J Biochem Mol Biol"},{"key":"key20180107184206_b27-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1182\/blood.V92.5.1497","article-title":"Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner","volume":"92","author":"Wang","year":"1998","journal-title":"Blood"},{"key":"key20180107184206_b28-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/path.1121","article-title":"Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas","volume":"198","author":"Gorgoulis","year":"2002","journal-title":"J Pathol"},{"key":"key20180107184206_b29-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/path.1582","article-title":"Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas","volume":"203","author":"Zacharatos","year":"2004","journal-title":"J Pathol"},{"key":"key20180107184206_b30-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.nucmedbio.2009.01.018","article-title":"Comparison of conventional and novel PET tracers for imaging mesothelioma in nude mice with subcutaneous and intrapleural xenografts","volume":"36","author":"Tsuji","year":"2009","journal-title":"Nucl Med Biol"},{"key":"key20180107184206_b31-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/FPC.0b013e32834e3572","article-title":"The influence of gemcitabine pathway polymorphisms on treatment outcome in patients with malignant mesothelioma","volume":"22","author":"Erculj","year":"2012","journal-title":"Pharmacogenet Genomics"},{"key":"key20180107184206_b32-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/j.1349-7006.2009.01196.x","article-title":"Ubiquitin-mediated control of oncogene and tumor suppressor gene products","volume":"100","author":"Kitagawa","year":"2009","journal-title":"Cancer Sci"},{"key":"key20180107184206_b33-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1756-9966-33-24","article-title":"CELLFOOD induces apoptosis in human mesothelioma and colorectal cancer cells by modulating p53, c-myc and pAkt signaling pathways","volume":"33","author":"Nuvoli","year":"2014","journal-title":"J Exp Clin Cancer Res"},{"key":"key20180107184206_b34-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1349-7006.2011.01931.x","article-title":"Synergistic effect of non-transmissible Sendai virus vector encoding the c-myc suppressor FUSE-binding protein-interacting repressor plus cisplatin in the treatment of malignant pleural mesothelioma","volume":"102","author":"Kitamura","year":"2011","journal-title":"Cancer Sci"},{"key":"key20180107184206_b35-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1179\/1607845412Y.0000000008","article-title":"Cytotoxic effect of arsenic trioxide on acute promyelocytic leukemia cells through suppression of NFkbeta-dependent induction of hTERT due to down-regulation of Pin1 transcription","volume":"17","author":"Ghaffari","year":"2012","journal-title":"Hematology"},{"key":"key20180107184206_b36-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1158\/0008-5472.CAN-13-2136","article-title":"JNK signaling mediates EPHA2-dependent tumor cell proliferation, motility, and cancer stem cell-like properties in non-small cell lung cancer","volume":"74","author":"Song","year":"2014","journal-title":"Cancer Res"},{"key":"key20180107184206_b37-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1756-8722-3-28","article-title":"Basic mechanisms of arsenic trioxide (ATO)-induced apoptosis in human leukemia (HL-60) cells","volume":"3","author":"Yedjou","year":"2010","journal-title":"J Hematol Oncol"},{"key":"key20180107184206_b38-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.bcp.2006.07.026","article-title":"Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin","volume":"72","author":"Jin","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"key20180107184206_b39-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/cr.2010.9","article-title":"Nuclear entry of active caspase-3 is facilitated by its p3-recognition-based specific cleavage activity","volume":"20","author":"Luo","year":"2010","journal-title":"Cell Res"},{"key":"key20180107184206_b40-ijo-46-01-0113","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.3892\/ijo.2014.2609","article-title":"E2F1 downregulation by arsenic trioxide in lung adenocarcinoma","volume":"45","author":"Lam","year":"2014","journal-title":"Int J Oncol"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2014.2716\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:22:53Z","timestamp":1598401373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2014.2716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,21]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,10,21]]},"published-print":{"date-parts":[[2015,1]]}},"alternative-id":["10.3892\/ijo.2014.2716"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2014.2716","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,21]]}}}